Skip to main content

Table 1 Ten significant changed lipid species of parthenolide treated papillary thyroid carcinoma cells

From: Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells

LipidIon

Class

IonFormula

CalMz

RT-(min)

Fold Change

P-value

VIP

PE(16:1/17:0)-H

PE

C38 H73 O8 N1 P1

702.5079

10.2916

0.751478

0.0013

3.050149

PC(34:1) + H

PC

C42 H83 O8 N1 P1

760.5851

11.2935

0.516481

0.024864

2.369579

LPC(28:0) + H

LPC

C36 H75 O7 N1 P1

664.5276

9.12472

2.341388

0.019202

2.103261

PC(18:0/20:4) + HCOO

PC

C47 H85 O10 N1 P1

854.5917

10.46383

1.488194

0.000975

1.749522

CerG3(d18:1/24:1) + H

CerG3

C60 H112 O18 N1

1134.787

11.45426

1.507216

0.034294

1.248035

PC(12:0e/16:0) + HCOO

PC

C37 H75 O9 N1 P1

708.5185

9.155024

2.497935

0.017275

1.236085

ChE(22:6) + NH4

ChE

C49 H80 O2 N1

714.6184

15.11703

1.920327

0.021625

1.219279

PC(16:0p/18:0) + Na

PC

C42 H84 O7 N1 P1 Na1

768.5878

10.90136

0.793529

0.043174

1.087524

LPE(18:0)-H

LPE

C23 H47 O7 N1 P1

480.3096

3.931845

1.398238

0.042449

1.079679

PI(19:0/20:4)-H

PI

C48 H84 O13 N0 P1

899.5655

9.793264

1.509611

0.035162

1.041106

  1. CerG3 simple glc series 3, ChE Cholesterol ester, LPC Lysophosphatidylcholine, LPE Lysophosphatidylethanolamine, PC Phosphatidylcholine, PE Phosphatidylethanolamine, PI Phosphatidylinositol, VIP the variable importance in the projection